Literature DB >> 29322886

Chronicity, crisis, and the 'end of AIDS'.

Thurka Sangaramoorthy1.   

Abstract

In biomedical, public health, and popular discourses, the 'end of AIDS' has emerged as a predominant way to understand the future of HIV research and prevention. This approach is predicated on structuring and responding to HIV in ways that underscore its presumed lifelong nature. In this article, I examine the phenomenon of HIV chronicity that undergirds the 'end of AIDS' discourse. In particular, I explore how the logic of HIV chronicity, induced by technological advances in treatment and global financial and political investments, intensifies long-term uncertainty and prolonged crisis. Focusing on over 10 years of anthropological and public health research in the United States, I argue that HIV chronicity, and subsequently, the 'end of AIDS' discourse, obscure the on-going HIV crisis in particular global communities, especially among marginalised and ageing populations who live in under-resourced areas. By tracing the 'end of AIDS' discourse in my field sites and in other global locations, I describe how HIV chronicity signals a continuing global crisis and persistent social precarity rather than a 'break' with a hopeless past or a promising future free from AIDS.

Entities:  

Keywords:  HIV/AIDS; United States; ageing; chronicity; health inequity

Mesh:

Year:  2018        PMID: 29322886      PMCID: PMC6080857          DOI: 10.1080/17441692.2018.1423701

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  60 in total

1.  HIV and aging--preparing for the challenges ahead.

Authors:  Edward J Mills; Till Bärnighausen; Joel Negin
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

2.  HIV and premature aging: A field still in its infancy.

Authors:  Jeffrey Martin; Paul Volberding
Journal:  Ann Intern Med       Date:  2010-10-05       Impact factor: 25.391

3.  A reality check for aspirational targets to end HIV.

Authors:  David P Wilson; Mark A Stoové; Margaret Hellard
Journal:  Lancet HIV       Date:  2014-12-23       Impact factor: 12.767

4.  The end of AIDS?

Authors: 
Journal:  Lancet HIV       Date:  2015-02-26       Impact factor: 12.767

5.  Treating the numbers: HIV/AIDS surveillance, subjectivity, and risk.

Authors:  Thurka Sangaramoorthy
Journal:  Med Anthropol       Date:  2012

Review 6.  Drug use as a driver of HIV risks: re-emerging and emerging issues.

Authors:  Nabila El-Bassel; Stacey A Shaw; Anindita Dasgupta; Steffanie A Strathdee
Journal:  Curr Opin HIV AIDS       Date:  2014-03       Impact factor: 4.283

7.  Toward an AIDS-free generation.

Authors:  Anthony S Fauci; Gregory K Folkers
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

8.  End of AIDS--hype versus hope.

Authors:  Wafaa M El-Sadr; Katherine Harripersaud; Ronald Bayer
Journal:  Science       Date:  2014-07-11       Impact factor: 47.728

9.  "You're awfully old to have this disease": experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS.

Authors:  Charles A Emlet
Journal:  Gerontologist       Date:  2006-12

10.  HIV Care Outcomes Among Blacks with Diagnosed HIV - United States, 2014.

Authors:  Andre F Dailey; Anna Satcher Johnson; Baohua Wu
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-03       Impact factor: 17.586

View more
  3 in total

1.  Counting, Coping, and Navigating the Flux: A Focused Ethnographic Study of HIV and Diabetes Self-Management.

Authors:  Chelsi W Ohueri; Alexandra A García; Julie A Zuñiga
Journal:  Qual Health Res       Date:  2021-12-20

2.  Anachronic: Viral Socialities and Project Time among HIV Support Groups in Barbados.

Authors:  David A B Murray
Journal:  Med Anthropol Q       Date:  2022-03-09

3.  "For us here, we remind ourselves": strategies and barriers to ART access and adherence among older Ugandans.

Authors:  Enid Schatz; Janet Seeley; Joel Negin; Helen A Weiss; Grace Tumwekwase; Elizabeth Kabunga; Phiona Nalubega; Joseph Mugisha
Journal:  BMC Public Health       Date:  2019-01-31       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.